25 XP   0   0   10

Hunan Hansen Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Hunan Hansen Pharmaceutical Co Ltd together

PenkeI guess you are interested in Hunan Hansen Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hunan Hansen Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hunan Hansen Pharmaceutical Co Ltd

I send you an email if I find something interesting about Hunan Hansen Pharmaceutical Co Ltd.

Quick analysis of Hunan Hansen Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Hunan Hansen Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.08
When do you have the money?
1 year
How often do you get paid?
92.5%

What is your share worth?

Current worth
¥3.70
Expected worth in 1 year
¥3.69
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
¥0.59
Return On Investment
10.9%

For what price can you sell your share?

Current Price per Share
¥5.48
Expected price per share
¥4.08 - ¥6.19
How sure are you?
50%

1. Valuation of Hunan Hansen Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥5.48

Intrinsic Value Per Share

¥-2.73 - ¥2.83

Total Value Per Share

¥0.97 - ¥6.53

2. Growth of Hunan Hansen Pharmaceutical Co Ltd (5 min.)




Is Hunan Hansen Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$258m$250m$11.4m4.4%

How much money is Hunan Hansen Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$5m$5.2m-$143.4k-2.8%
Net Profit Margin15.8%16.5%--

How much money comes from the company's main activities?

3. Financial Health of Hunan Hansen Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Hunan Hansen Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Hunan Hansen Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Hunan Hansen Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Hunan Hansen Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Hunan Hansen Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hunan Hansen Pharmaceutical Co Ltd is ¥5.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hunan Hansen Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hunan Hansen Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.70. Based on the TTM, the Book Value Change Per Share is ¥0.00 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.15 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hunan Hansen Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.010.2%0.010.2%0.010.2%0.010.2%
Usd Book Value Change Per Share0.010.1%0.000.0%0.010.2%0.010.1%0.010.1%
Usd Dividend Per Share0.000.0%0.020.4%0.000.0%0.010.1%0.010.1%
Usd Total Gains Per Share0.010.1%0.020.4%0.010.2%0.010.2%0.010.2%
Usd Price Per Share0.97-0.90-0.89-1.12-1.93-
Price to Earnings Ratio46.30-26.14-24.51-30.47-67.01-
Price-to-Total Gains Ratio186.70-102.24-86.50-134.19-218.85-
Price to Book Ratio1.89-1.74-1.79-2.55-5.44-
Price-to-Total Gains Ratio186.70-102.24-86.50-134.19-218.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.758432
Number of shares1318
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.020.01
Gains per Quarter (1318 shares)27.1316.93
Gains per Year (1318 shares)108.5367.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1111-399274158
2223-62085481126
3334-831781122194
4445-11426109162262
5556-14535136203330
6668-17644163243398
7779-19753190284466
8890-22862217325534
91002-25971244365602
101113-281080272406670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%55.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%18.02.00.090.0%35.05.00.087.5%49.06.00.089.1%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.00.03.092.5%42.00.013.076.4%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%54.01.00.098.2%

Fundamentals of Hunan Hansen Pharmaceutical Co Ltd

About Hunan Hansen Pharmaceutical Co Ltd

Hunan Hansen Pharmaceutical Co., Ltd. produces and sells traditional Chinese preparations in China and internationally. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Yiyang, China.

Fundamental data was last updated by Penke on 2024-03-24 01:49:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hunan Hansen Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hunan Hansen Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hunan Hansen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.0% means that ¥0.09 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The MRQ is 9.0%. The company is making a profit. +1
  • The TTM is 15.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ9.0%TTM15.8%-6.8%
TTM15.8%YOY16.5%-0.8%
TTM15.8%5Y16.7%-0.9%
5Y16.7%10Y15.1%+1.5%
1.1.2. Return on Assets

Shows how efficient Hunan Hansen Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hunan Hansen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.8% Return on Assets means that Hunan Hansen Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.8%TTM1.6%-0.8%
TTM1.6%YOY1.7%-0.1%
TTM1.6%5Y1.8%-0.2%
5Y1.8%10Y1.8%+0.0%
1.1.3. Return on Equity

Shows how efficient Hunan Hansen Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hunan Hansen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.0% Return on Equity means Hunan Hansen Pharmaceutical Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The MRQ is 1.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.0%TTM1.9%-0.9%
TTM1.9%YOY2.1%-0.1%
TTM1.9%5Y2.3%-0.3%
5Y2.3%10Y2.3%0.0%

1.2. Operating Efficiency of Hunan Hansen Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hunan Hansen Pharmaceutical Co Ltd is operating .

  • Measures how much profit Hunan Hansen Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hunan Hansen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 6.0% means the company generated ¥0.06  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The MRQ is 6.0%. The company is operating less efficient.
  • The TTM is 15.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ6.0%TTM15.8%-9.8%
TTM15.8%YOY12.7%+3.1%
TTM15.8%5Y15.3%+0.5%
5Y15.3%10Y8.2%+7.1%
1.2.2. Operating Ratio

Measures how efficient Hunan Hansen Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.19 means that the operating costs are ¥1.19 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The MRQ is 1.190. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.118. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.190TTM1.118+0.072
TTM1.118YOY1.148-0.030
TTM1.1185Y1.128-0.010
5Y1.12810Y0.737+0.392

1.3. Liquidity of Hunan Hansen Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hunan Hansen Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.09 means the company has ¥2.09 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The MRQ is 2.087. The company is able to pay all its short-term debts. +1
  • The TTM is 2.173. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.087TTM2.173-0.086
TTM2.173YOY1.644+0.529
TTM2.1735Y1.793+0.381
5Y1.79310Y0.954+0.839
1.3.2. Quick Ratio

Measures if Hunan Hansen Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hunan Hansen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.28 means the company can pay off ¥1.28 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The MRQ is 1.284. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.177. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.284TTM1.177+0.107
TTM1.177YOY1.022+0.155
TTM1.1775Y1.026+0.151
5Y1.02610Y1.210-0.184

1.4. Solvency of Hunan Hansen Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hunan Hansen Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hunan Hansen Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.18 means that Hunan Hansen Pharmaceutical Co Ltd assets are financed with 17.9% credit (debt) and the remaining percentage (100% - 17.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The MRQ is 0.179. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.179. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.179TTM0.179-0.001
TTM0.179YOY0.176+0.003
TTM0.1795Y0.183-0.003
5Y0.18310Y0.184-0.001
1.4.2. Debt to Equity Ratio

Measures if Hunan Hansen Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hunan Hansen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 21.8% means that company has ¥0.22 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The MRQ is 0.218. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.218. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.218TTM0.218-0.001
TTM0.218YOY0.214+0.005
TTM0.2185Y0.225-0.006
5Y0.22510Y0.232-0.007

2. Market Valuation of Hunan Hansen Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hunan Hansen Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hunan Hansen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 46.30 means the investor is paying ¥46.30 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The EOD is 36.140. Based on the earnings, the company is overpriced. -1
  • The MRQ is 46.297. Based on the earnings, the company is overpriced. -1
  • The TTM is 26.140. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD36.140MRQ46.297-10.156
MRQ46.297TTM26.140+20.156
TTM26.140YOY24.509+1.631
TTM26.1405Y30.471-4.330
5Y30.47110Y67.011-36.541
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The EOD is 22.013. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 28.199. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -98.930. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD22.013MRQ28.199-6.186
MRQ28.199TTM-98.930+127.129
TTM-98.930YOY41.277-140.207
TTM-98.9305Y17.383-116.313
5Y17.38310Y-0.719+18.102
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hunan Hansen Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Hunan Hansen Pharmaceutical Co Ltd:

  • The EOD is 1.479. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.895. Based on the equity, the company is underpriced. +1
  • The TTM is 1.737. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.479MRQ1.895-0.416
MRQ1.895TTM1.737+0.158
TTM1.737YOY1.787-0.050
TTM1.7375Y2.552-0.814
5Y2.55210Y5.440-2.888
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hunan Hansen Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.038-0.004+110%0.077-52%0.056-32%0.041-9%
Book Value Per Share--3.7053.755-1%3.591+3%3.309+12%2.851+30%
Current Ratio--2.0872.173-4%1.644+27%1.793+16%0.954+119%
Debt To Asset Ratio--0.1790.1790%0.176+2%0.183-2%0.184-3%
Debt To Equity Ratio--0.2180.2180%0.214+2%0.225-3%0.232-6%
Dividend Per Share--0.0000.153-100%0.002-96%0.037-100%0.055-100%
Eps--0.0380.073-48%0.075-50%0.074-49%0.063-40%
Free Cash Flow Per Share--0.0620.071-12%-0.006+109%0.042+47%0.041+52%
Free Cash Flow To Equity Per Share---0.017-0.107+520%-0.020+15%-0.016-5%0.020-186%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.830--------
Intrinsic Value_10Y_min---2.732--------
Intrinsic Value_1Y_max--0.181--------
Intrinsic Value_1Y_min--0.033--------
Intrinsic Value_3Y_max--0.623--------
Intrinsic Value_3Y_min---0.166--------
Intrinsic Value_5Y_max--1.158--------
Intrinsic Value_5Y_min---0.653--------
Market Cap2757536000.000-28%3532464000.0003279606000.000+8%3222996000.000+10%4070086830.150-13%7014842751.675-50%
Net Profit Margin--0.0900.158-43%0.165-46%0.167-46%0.151-41%
Operating Margin--0.0600.158-62%0.127-53%0.153-61%0.082-27%
Operating Ratio--1.1901.118+6%1.148+4%1.128+5%0.737+62%
Pb Ratio1.479-28%1.8951.737+9%1.787+6%2.552-26%5.440-65%
Pe Ratio36.140-28%46.29726.140+77%24.509+89%30.471+52%67.011-31%
Price Per Share5.480-28%7.0206.518+8%6.405+10%8.079-13%13.936-50%
Price To Free Cash Flow Ratio22.013-28%28.199-98.930+451%41.277-32%17.383+62%-0.719+103%
Price To Total Gains Ratio145.742-28%186.699102.239+83%86.505+116%134.185+39%218.848-15%
Quick Ratio--1.2841.177+9%1.022+26%1.026+25%1.210+6%
Return On Assets--0.0080.016-47%0.017-51%0.018-54%0.018-54%
Return On Equity--0.0100.019-47%0.021-51%0.023-55%0.023-55%
Total Gains Per Share--0.0380.149-75%0.079-53%0.093-59%0.096-61%
Usd Book Value--258004024.057261521344.517-1%250094485.452+3%230542108.961+12%198611959.308+30%
Usd Book Value Change Per Share--0.005-0.001+110%0.011-52%0.008-32%0.006-9%
Usd Book Value Per Share--0.5130.520-1%0.497+3%0.458+12%0.395+30%
Usd Dividend Per Share--0.0000.021-100%0.000-96%0.005-100%0.008-100%
Usd Eps--0.0050.010-48%0.010-50%0.010-49%0.009-40%
Usd Free Cash Flow--4334297.2664934097.909-12%-390541.880+109%2953569.633+47%2711946.374+60%
Usd Free Cash Flow Per Share--0.0090.010-12%-0.001+109%0.006+47%0.006+52%
Usd Free Cash Flow To Equity Per Share---0.002-0.015+520%-0.003+15%-0.002-5%0.003-186%
Usd Market Cap381642982.400-28%488893017.600453897470.400+8%446062646.400+10%563300017.293-13%970854236.832-50%
Usd Price Per Share0.758-28%0.9720.902+8%0.886+10%1.118-13%1.929-50%
Usd Profit--2639999.6135096021.014-48%5239478.176-50%5133987.908-49%4418354.309-40%
Usd Revenue--29405770.64731799252.415-8%31592142.424-7%30315624.027-3%28906964.866+2%
Usd Total Gains Per Share--0.0050.021-75%0.011-53%0.013-59%0.013-61%
 EOD+4 -4MRQTTM+11 -24YOY+15 -205Y+13 -2210Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of Hunan Hansen Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.140
Price to Book Ratio (EOD)Between0-11.479
Net Profit Margin (MRQ)Greater than00.090
Operating Margin (MRQ)Greater than00.060
Quick Ratio (MRQ)Greater than11.284
Current Ratio (MRQ)Greater than12.087
Debt to Asset Ratio (MRQ)Less than10.179
Debt to Equity Ratio (MRQ)Less than10.218
Return on Equity (MRQ)Greater than0.150.010
Return on Assets (MRQ)Greater than0.050.008
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Hunan Hansen Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.599
Ma 20Greater thanMa 505.404
Ma 50Greater thanMa 1005.493
Ma 100Greater thanMa 2006.215
OpenGreater thanClose5.350
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,269,740
Total Liabilities405,549
Total Stockholder Equity1,864,191
 As reported
Total Liabilities 405,549
Total Stockholder Equity+ 1,864,191
Total Assets = 2,269,740

Assets

Total Assets2,269,740
Total Current Assets809,846
Long-term Assets1,439,434
Total Current Assets
Cash And Cash Equivalents 65,601
Short-term Investments 160,122
Net Receivables 338,214
Inventory 241,209
Other Current Assets 4,699
Total Current Assets  (as reported)809,846
Total Current Assets  (calculated)809,846
+/- 0
Long-term Assets
Property Plant Equipment 408,466
Goodwill 14,789
Intangible Assets 30,667
Other Assets 179,460
Long-term Assets  (as reported)1,439,434
Long-term Assets  (calculated)633,382
+/- 806,052

Liabilities & Shareholders' Equity

Total Current Liabilities387,985
Long-term Liabilities17,564
Total Stockholder Equity1,864,191
Total Current Liabilities
Short Long Term Debt 90,106
Accounts payable 29,103
Other Current Liabilities 244,822
Total Current Liabilities  (as reported)387,985
Total Current Liabilities  (calculated)364,031
+/- 23,954
Long-term Liabilities
Other Liabilities 17,564
Long-term Liabilities  (as reported)17,564
Long-term Liabilities  (calculated)17,564
+/- 0
Total Stockholder Equity
Common Stock503,200
Retained Earnings 1,120,097
Other Stockholders Equity 6,777
Total Stockholder Equity (as reported)1,864,191
Total Stockholder Equity (calculated)1,630,075
+/- 234,116
Other
Capital Stock503,200
Common Stock Shares Outstanding 503,200
Net Debt 24,505
Net Invested Capital 1,954,297
Net Tangible Assets 1,818,735
Net Working Capital 442,321
Property Plant and Equipment Gross 408,466



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312008-12-312007-12-31
> Total Assets 
174,255
214,926
247,196
265,484
921,622
926,768
948,053
952,978
899,433
926,723
938,596
977,340
1,007,773
1,049,558
1,041,870
1,112,027
1,140,187
1,170,940
1,322,117
1,331,757
1,295,146
1,321,625
1,367,772
1,364,958
1,373,920
1,359,333
1,380,316
1,330,929
1,346,911
1,381,882
1,674,389
1,693,926
1,668,737
1,694,738
1,700,410
1,734,140
1,710,416
1,792,261
1,798,361
1,835,796
1,848,425
1,895,742
1,882,906
1,941,266
1,813,897
1,838,835
1,888,642
1,921,372
2,037,929
2,043,914
2,111,282
2,132,385
2,203,980
2,326,804
2,290,944
2,368,623
2,278,678
2,269,740
2,269,7402,278,6782,368,6232,290,9442,326,8042,203,9802,132,3852,111,2822,043,9142,037,9291,921,3721,888,6421,838,8351,813,8971,941,2661,882,9061,895,7421,848,4251,835,7961,798,3611,792,2611,710,4161,734,1401,700,4101,694,7381,668,7371,693,9261,674,3891,381,8821,346,9111,330,9291,380,3161,359,3331,373,9201,364,9581,367,7721,321,6251,295,1461,331,7571,322,1171,170,9401,140,1871,112,0271,041,8701,049,5581,007,773977,340938,596926,723899,433952,978948,053926,768921,622265,484247,196214,926174,255
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
506,409
506,879
490,941
518,701
527,907
572,972
593,862
634,348
512,901
529,075
527,456
555,186
597,659
575,473
535,410
560,645
621,100
711,302
865,402
933,342
816,526
809,846
809,846816,526933,342865,402711,302621,100560,645535,410575,473597,659555,186527,456529,075512,901634,348593,862572,972527,907518,701490,941506,879506,409000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,082
93,693
82,716
84,243
53,942
114,866
116,611
133,823
85,847
121,798
103,561
133,987
181,832
126,046
90,311
90,759
116,278
148,065
145,406
143,954
109,095
65,601
65,601109,095143,954145,406148,065116,27890,75990,311126,046181,832133,987103,561121,79885,847133,823116,611114,86653,94284,24382,71693,693108,082000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
0
0
0
0
0
0
0
0
0
49,240
40,085
48,471
105,336
135,822
200,718
99,584
160,122
160,12299,584200,718135,822105,33648,47140,08549,24000000000020,0000000000000000000000000000000000000000000
       Net Receivables 
64,298
65,807
89,509
103,175
113,111
130,000
152,062
120,959
133,201
164,823
149,653
180,343
155,619
159,429
132,290
177,401
179,746
182,048
172,026
199,274
225,943
224,177
224,156
258,755
263,697
264,990
310,471
295,594
270,151
319,194
249,577
303,092
247,657
289,596
284,033
341,051
285,241
313,423
296,128
293,825
306,157
294,401
350,509
369,802
300,539
298,214
312,767
333,724
314,238
284,139
274,740
314,333
342,453
333,817
332,530
238,710
348,429
338,214
338,214348,429238,710332,530333,817342,453314,333274,740284,139314,238333,724312,767298,214300,539369,802350,509294,401306,157293,825296,128313,423285,241341,051284,033289,596247,657303,092249,577319,194270,151295,594310,471264,990263,697258,755224,156224,177225,943199,274172,026182,048179,746177,401132,290159,429155,619180,343149,653164,823133,201120,959152,062130,000113,111103,17589,50965,80764,298
       Other Current Assets 
1,107
936
3,759
3,733
1,544
1,048
683
3,249
688
15,869
14,826
22,811
26,077
40,872
39,267
41,532
42,803
43,799
26,681
19,820
16,437
22,558
38,383
34,838
28,843
19,798
33,339
17,640
32,670
25,658
32,776
56,152
35,339
26,674
27,081
15,072
9,301
9,424
18,119
4,805
20,834
20,000
21,320
33,656
19,066
15,095
23,994
5,212
1,006
74,656
17,746
21,345
11,037
16,770
5,028
285
19,937
4,699
4,69919,9372855,02816,77011,03721,34517,74674,6561,0065,21223,99415,09519,06633,65621,32020,00020,8344,80518,1199,4249,30115,07227,08126,67435,33956,15232,77625,65832,67017,64033,33919,79828,84334,83838,38322,55816,43719,82026,68143,79942,80341,53239,26740,87226,07722,81114,82615,8696883,2496831,0481,5443,7333,7599361,107
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,317,095
1,320,518
1,322,770
1,289,044
1,306,918
1,300,996
1,309,760
1,361,185
1,366,186
1,440,270
1,468,442
1,575,872
1,571,740
1,582,881
1,615,501
1,425,542
1,435,281
1,462,153
1,439,434
1,439,4341,462,1531,435,2811,425,5421,615,5011,582,8811,571,7401,575,8721,468,4421,440,2701,366,1861,361,1851,309,7601,300,9961,306,9181,289,0441,322,7701,320,5181,317,095000000000000000000000000000000000000000
       Property Plant Equipment 
56,230
62,003
75,433
65,417
76,527
67,570
77,432
67,317
78,595
67,495
100,548
107,046
147,304
141,644
194,575
219,657
267,798
262,430
446,592
427,265
439,585
444,464
442,786
453,780
458,415
454,212
455,406
452,690
460,740
455,374
455,891
448,729
444,815
465,676
461,897
458,521
461,168
464,920
496,700
500,856
497,511
494,422
497,005
493,580
480,963
479,932
485,626
482,861
477,141
473,432
470,750
460,788
461,012
447,164
431,743
423,436
414,181
408,466
408,466414,181423,436431,743447,164461,012460,788470,750473,432477,141482,861485,626479,932480,963493,580497,005494,422497,511500,856496,700464,920461,168458,521461,897465,676444,815448,729455,891455,374460,740452,690455,406454,212458,415453,780442,786444,464439,585427,265446,592262,430267,798219,657194,575141,644147,304107,046100,54867,49578,59567,31777,43267,57076,52765,41775,43362,00356,230
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
156,288
156,288
156,288
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
164,114
117,992
117,992
117,992
117,992
92,656
92,656
92,656
92,656
53,027
53,027
53,027
53,027
14,789
14,789
14,789
14,789
14,78914,78914,78914,78953,02753,02753,02753,02792,65692,65692,65692,656117,992117,992117,992117,992164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114164,114156,288156,288156,2880000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
451,453
458,031
537,573
547,384
558,112
566,091
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000566,091558,112547,384537,573458,031451,453000000000000000000000000000000000000
       Intangible Assets 
16,574
17,355
6,251
15,003
5,488
14,239
4,890
14,842
4,166
14,084
3,517
19,397
2,757
22,615
1,848
21,495
1,070
20,500
87,956
275,018
272,490
270,595
275,468
273,191
270,637
268,104
265,725
263,169
260,632
258,127
255,941
253,394
250,848
248,491
246,296
243,722
77,067
74,490
71,913
72,516
40,149
67,389
61,803
59,238
56,941
54,569
52,099
49,713
47,467
45,040
42,580
40,116
37,653
35,189
33,721
32,226
31,718
30,667
30,66731,71832,22633,72135,18937,65340,11642,58045,04047,46749,71352,09954,56956,94159,23861,80367,38940,14972,51671,91374,49077,067243,722246,296248,491250,848253,394255,941258,127260,632263,169265,725268,104270,637273,191275,468270,595272,490275,01887,95620,5001,07021,4951,84822,6152,75719,3973,51714,0844,16614,8424,89014,2395,48815,0036,25117,35516,574
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,397
11,465
11,575
14,346
14,461
16,039
490,437
79,498
80,592
141,320
144,697
279,813
280,869
274,006
274,508
134,598
136,512
140,771
138,148
138,148140,771136,512134,598274,508274,006280,869279,813144,697141,32080,59279,498490,43716,03914,46114,34611,57511,46510,397000000000000000000000000000000000000000
> Total Liabilities 
86,490
84,666
67,686
73,016
61,136
49,762
49,230
40,282
45,240
55,324
54,946
73,477
87,207
106,873
76,761
121,660
126,454
134,299
214,463
191,133
204,927
206,805
214,585
182,653
165,665
135,698
126,831
124,009
122,804
147,604
415,882
405,883
504,939
517,968
481,178
478,516
430,504
486,668
435,016
431,392
405,943
424,584
352,928
361,602
265,000
261,992
293,921
284,654
373,407
327,897
368,990
340,906
381,391
455,000
396,812
413,833
433,371
405,549
405,549433,371413,833396,812455,000381,391340,906368,990327,897373,407284,654293,921261,992265,000361,602352,928424,584405,943431,392435,016486,668430,504478,516481,178517,968504,939405,883415,882147,604122,804124,009126,831135,698165,665182,653214,585206,805204,927191,133214,463134,299126,454121,66076,761106,87387,20773,47754,94655,32445,24040,28249,23049,76261,13673,01667,68684,66686,490
   > Total Current Liabilities 
86,490
84,666
67,336
72,666
61,136
49,762
46,852
37,928
42,968
53,114
52,819
70,059
83,498
103,382
73,226
113,362
117,972
126,131
162,253
139,400
153,398
195,497
194,005
162,567
146,073
116,601
108,228
104,941
104,383
129,354
397,159
385,302
484,648
498,026
461,926
459,802
412,830
469,528
417,376
413,825
388,915
408,105
336,524
345,781
249,512
244,552
273,431
264,871
354,332
309,528
351,109
323,843
364,982
439,261
380,237
394,985
415,191
387,985
387,985415,191394,985380,237439,261364,982323,843351,109309,528354,332264,871273,431244,552249,512345,781336,524408,105388,915413,825417,376469,528412,830459,802461,926498,026484,648385,302397,159129,354104,383104,941108,228116,601146,073162,567194,005195,497153,398139,400162,253126,131117,972113,36273,226103,38283,49870,05952,81953,11442,96837,92846,85249,76261,13672,66667,33684,66686,490
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
260,000
220,000
220,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000220,800220,000260,000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
260,000
220,000
220,800
190,800
220,800
170,800
140,000
178,000
148,000
218,000
178,000
131,792
102,901
103,474
150,159
120,150
120,150
130,131
90,106
90,106130,131120,150120,150150,159103,474102,901131,792178,000218,000148,000178,000140,000170,800220,800190,800220,800220,000260,000000000000000000000000000000000000000000
       Accounts payable 
11,251
12,290
12,358
10,555
10,425
9,303
15,596
12,310
13,813
17,415
12,314
14,526
15,400
16,218
18,523
28,248
24,329
20,659
77,224
58,775
62,863
72,165
64,999
51,079
44,835
42,068
37,792
36,571
35,138
35,468
36,370
35,649
31,326
36,923
40,119
47,519
38,297
40,695
50,779
49,046
44,038
47,047
49,228
52,709
36,221
38,499
38,119
37,914
40,361
32,714
51,440
33,701
40,184
37,720
43,631
34,253
29,890
29,103
29,10329,89034,25343,63137,72040,18433,70151,44032,71440,36137,91438,11938,49936,22152,70949,22847,04744,03849,04650,77940,69538,29747,51940,11936,92331,32635,64936,37035,46835,13836,57137,79242,06844,83551,07964,99972,16562,86358,77577,22420,65924,32928,24818,52316,21815,40014,52612,31417,41513,81312,31015,5969,30310,42510,55512,35812,29011,251
       Other Current Liabilities 
32,739
19,676
14,978
22,111
27,211
26,959
31,256
25,618
29,155
35,699
40,505
55,533
68,098
87,164
54,703
85,114
93,643
105,472
85,029
80,624
90,535
83,333
89,006
71,489
61,239
74,533
62,073
55,718
52,003
70,154
74,128
60,883
64,182
78,453
76,847
67,323
42,495
79,579
58,015
80,218
96,374
112,947
42,096
48,150
19,469
41,974
26,774
56,887
64,918
74,598
123,599
165,782
181,624
228,937
175,317
23,559
143,859
244,822
244,822143,85923,559175,317228,937181,624165,782123,59974,59864,91856,88726,77441,97419,46948,15042,096112,94796,37480,21858,01579,57942,49567,32376,84778,45364,18260,88374,12870,15452,00355,71862,07374,53361,23971,48989,00683,33390,53580,62485,029105,47293,64385,11454,70387,16468,09855,53340,50535,69929,15525,61831,25626,95927,21122,11114,97819,67632,739
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,567
17,028
16,479
16,404
15,821
15,488
17,440
20,490
19,783
19,075
18,369
17,881
17,064
16,409
15,739
16,575
18,848
18,180
17,564
17,56418,18018,84816,57515,73916,40917,06417,88118,36919,07519,78320,49017,44015,48815,82116,40416,47917,02817,567000000000000000000000000000000000000000
       Other Liabilities 
0
0
350
350
0
0
2,372
2,310
2,249
2,188
2,127
3,418
3,709
3,488
3,494
8,280
8,445
8,167
12,187
11,733
11,529
11,308
13,544
13,245
12,946
12,647
12,348
13,008
12,556
12,580
13,248
15,301
15,207
15,052
14,557
14,213
17,674
17,140
17,640
17,567
17,028
16,479
16,404
15,821
15,488
17,440
20,490
19,783
19,075
18,369
17,881
17,064
16,409
15,739
16,575
0
18,180
17,564
17,56418,180016,57515,73916,40917,06417,88118,36919,07519,78320,49017,44015,48815,82116,40416,47917,02817,56717,64017,14017,67414,21314,55715,05215,20715,30113,24812,58012,55613,00812,34812,64712,94613,24513,54411,30811,52911,73312,1878,1678,4458,2803,4943,4883,7093,4182,1272,1882,2492,3102,3720035035000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,567
21,484
21,308
21,168
20,987
20,812
17,464
17,290
17,116
17,313
17,136
16,959
16,781
16,603
16,425
16,247
16,069
15,890
15,712
0
15,486
15,307
15,30715,486015,71215,89016,06916,24716,42516,60316,78116,95917,13617,31317,11617,29017,46420,81220,98721,16821,30821,48421,567000000000000000000000000000000000000
> Total Stockholder Equity
87,765
130,260
179,510
192,467
860,486
877,006
898,824
912,696
854,193
871,399
883,651
903,863
920,566
942,685
965,110
990,367
1,013,733
1,036,641
1,075,943
1,108,100
1,058,023
1,082,098
1,119,531
1,148,153
1,173,518
1,188,470
1,217,608
1,206,923
1,224,110
1,234,281
1,258,425
1,287,961
1,163,716
1,176,688
1,219,231
1,255,625
1,279,913
1,305,593
1,363,344
1,404,404
1,442,482
1,471,158
1,529,978
1,579,664
1,548,898
1,576,843
1,594,721
1,636,718
1,664,522
1,716,017
1,742,293
1,791,478
1,822,590
1,871,804
1,894,132
1,954,791
1,845,307
1,864,191
1,864,1911,845,3071,954,7911,894,1321,871,8041,822,5901,791,4781,742,2931,716,0171,664,5221,636,7181,594,7211,576,8431,548,8981,579,6641,529,9781,471,1581,442,4821,404,4041,363,3441,305,5931,279,9131,255,6251,219,2311,176,6881,163,7161,287,9611,258,4251,234,2811,224,1101,206,9231,217,6081,188,4701,173,5181,148,1531,119,5311,082,0981,058,0231,108,1001,075,9431,036,6411,013,733990,367965,110942,685920,566903,863883,651871,399854,193912,696898,824877,006860,486192,467179,510130,26087,765
   Common Stock
10,000
55,000
55,000
55,000
74,000
74,000
74,000
74,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
296,000
503,200
503,200
503,200
503,200
503,200
503,200
503,200
503,200
503,200
503,200
503,200
503,200
503,200
503,200
503,200
0
503,200
503,200
503,200503,2000503,200503,200503,200503,200503,200503,200503,200503,200503,200503,200503,200503,200503,200503,200503,200296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000296,000148,000148,000148,000148,000148,000148,000148,000148,000148,000148,000148,000148,00074,00074,00074,00074,00055,00055,00055,00010,000
   Retained Earnings 
64,635
45,623
90,847
103,805
123,340
139,859
147,293
161,165
102,662
119,869
123,514
143,726
160,429
182,548
197,112
222,369
245,734
268,643
297,029
369,621
319,544
343,619
381,052
409,674
435,039
449,991
479,129
507,566
529,754
539,924
564,068
593,604
469,359
482,331
524,875
561,268
585,556
611,237
672,412
620,887
662,858
694,264
845,095
882,038
860,585
892,108
913,501
959,233
968,495
1,011,352
1,024,153
1,075,977
1,103,035
1,154,227
1,161,315
1,058,690
1,101,022
1,120,097
1,120,0971,101,0221,058,6901,161,3151,154,2271,103,0351,075,9771,024,1531,011,352968,495959,233913,501892,108860,585882,038845,095694,264662,858620,887672,412611,237585,556561,268524,875482,331469,359593,604564,068539,924529,754507,566479,129449,991435,039409,674381,052343,619319,544369,621297,029268,643245,734222,369197,112182,548160,429143,726123,514119,869102,662161,165147,293139,859123,340103,80590,84745,62364,635
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,062
1,900
-1,993
-4,722
-4,988
7,755
-1,558
-5,135
-8,651
-12,385
-9,485
-847
12,627
9,988
14,042
10,714
-4,500
0
6,969
6,777
6,7776,9690-4,50010,71414,0429,98812,627-847-9,485-12,385-8,651-5,135-1,5587,755-4,988-4,722-1,9931,9001,06200000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue919,054
Cost of Revenue-252,361
Gross Profit666,692666,692
 
Operating Income (+$)
Gross Profit666,692
Operating Expense-771,629
Operating Income147,424-104,937
 
Operating Expense (+$)
Research Development45,013
Selling General Administrative414,102
Selling And Marketing Expenses-
Operating Expense771,629459,115
 
Net Interest Income (+$)
Interest Income625
Interest Expense-3,969
Other Finance Cost-367
Net Interest Income-2,977
 
Pretax Income (+$)
Operating Income147,424
Net Interest Income-2,977
Other Non-Operating Income Expenses-
Income Before Tax (EBT)162,858147,424
EBIT - interestExpense = -3,969
147,284
151,253
Interest Expense3,969
Earnings Before Interest and Taxes (EBIT)-166,827
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax162,858
Tax Provision-15,575
Net Income From Continuing Ops147,284147,284
Net Income147,284
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,977
 

Technical Analysis of Hunan Hansen Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hunan Hansen Pharmaceutical Co Ltd. The general trend of Hunan Hansen Pharmaceutical Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hunan Hansen Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hunan Hansen Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 5.6886705107084 < 5.72 < 6.19.

The bearish price targets are: 4.96 > 4.08.

Tweet this
Hunan Hansen Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hunan Hansen Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hunan Hansen Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hunan Hansen Pharmaceutical Co Ltd. The current macd is 0.00868996.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hunan Hansen Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hunan Hansen Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hunan Hansen Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hunan Hansen Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHunan Hansen Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hunan Hansen Pharmaceutical Co Ltd. The current adx is 16.61.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hunan Hansen Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Hunan Hansen Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hunan Hansen Pharmaceutical Co Ltd. The current sar is 5.67619072.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hunan Hansen Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hunan Hansen Pharmaceutical Co Ltd. The current rsi is 51.60. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Hunan Hansen Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartHunan Hansen Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hunan Hansen Pharmaceutical Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hunan Hansen Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hunan Hansen Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartHunan Hansen Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hunan Hansen Pharmaceutical Co Ltd. The current cci is 44.15.

Hunan Hansen Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartHunan Hansen Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hunan Hansen Pharmaceutical Co Ltd. The current cmo is 6.99094211.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Hunan Hansen Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHunan Hansen Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hunan Hansen Pharmaceutical Co Ltd. The current willr is -48.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hunan Hansen Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hunan Hansen Pharmaceutical Co Ltd Daily Williams %R ChartHunan Hansen Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hunan Hansen Pharmaceutical Co Ltd.

Hunan Hansen Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hunan Hansen Pharmaceutical Co Ltd. The current atr is 0.19725369.

Hunan Hansen Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartHunan Hansen Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hunan Hansen Pharmaceutical Co Ltd. The current obv is 626,187,886.

Hunan Hansen Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartHunan Hansen Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hunan Hansen Pharmaceutical Co Ltd. The current mfi is 61.72.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hunan Hansen Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartHunan Hansen Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hunan Hansen Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Hunan Hansen Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hunan Hansen Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.599
Ma 20Greater thanMa 505.404
Ma 50Greater thanMa 1005.493
Ma 100Greater thanMa 2006.215
OpenGreater thanClose5.350
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hunan Hansen Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hunan Hansen Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hunan Hansen Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hunan Hansen Pharmaceutical Co Ltd

I send you an email if I find something interesting about Hunan Hansen Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hunan Hansen Pharmaceutical Co Ltd.

Receive notifications about Hunan Hansen Pharmaceutical Co Ltd in your mailbox!